Two professional chief physicians instruct the Internal Medicine Department (IMD). They use stem cell technology to treat many kinds of the complicated diseases that the IMD specialize in such as diabetes (type1, type2), apituitarism disease, hypothyroidism disease, idiopathic sarcoidosis, osteoporosis (embrace Perthes' disease), rheumatoid arthritis, ankylosing spondylitis, systemic lupus erythematosus, vasculitis, sicca syndrome and so on. They have treated about 300 patients successfully. The treatment is safe and reliable, the results are remarkable. The outcomes have significantly improved the patients' quality of life.
Diabetes is a metabolic disorder which is the cause of many kinds of other diseases. Its main characteristic is chronic hyperglycemia. There are two reasons that cause the blood sugar levels to heighten. One is insulin secretion and the other is function flaw, another reason is that both conditions may exist. Diabetes is divided into type 1, type 2, and other special types, including gestational diabetes and so on.
With people's living conditions improving, and as a result, life expectancy increasing worldwide, according to a WHO report, in 1997, there were about 135 millions diabetics in the world and this number is expected to rise to 300 millions by 2025.
Stem cell therapy is a new method; it was developed with molecular biology, molecular immunology and cell biology. It can treat diabetes from the cell and the gene level and cure diabetes on the clinical. It has minor side effects. The merits are the minor side effects and the steadying of the blood sugar levels. The effect is good. We use self activation of the island Langerhans' stem cell and stem cell transplantation to cure diabetes. The types of transplantation cells are embryo stem cells, the insulin type of cell which originates in the embryo and develops into bone mesenchymal stem cells.